Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants

por Glab-ampai, Kittirat, Kaewchim, Kanasap, Saenlom, Thanatsaran, Thepsawat, Watayagorn, Mahasongkram, Kodchakorn, Sookrung, Nitat, Chaicumpa, Wanpen, Chulanetra, Monrat
Publicado 2022

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies

por Kaewchim, Kanasap, Glab-ampai, Kittirat, Mahasongkram, Kodchakorn, Saenlom, Thanatsaran, Thepsawat, Watayagorn, Chulanetra, Monrat, Choowongkomon, Kiattawee, Sookrung, Nitat, Chaicumpa, Wanpen
Publicado 2023

Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252

por Kaewchim, Kanasap, Glab-ampai, Kittirat, Mahasongkram, Kodchakorn, Saenlom, Thanatsaran, Thepsawat, Watayagorn, Chulanetra, Monrat, Choowongkomon, Kiattawee, Sookrung, Nitat, Chaicumpa, Wanpen
Publicado 2023

Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase

por Glab-ampai, Kittirat, Kaewchim, Kanasap, Thavorasak, Techit, Saenlom, Thanatsaran, Thepsawat, Watayagorn, Mahasongkram, Kodchakorn, Thueng-In, Kanyarat, Sookrung, Nitat, Chaicumpa, Wanpen, Chulanetra, Monrat
Publicado 2022